| S.No | Name of the Students | Guide | Project Title |
| 1 | Hoviya S S | Dr. R. Kamaraj | Project management strategies involved in the development of biosimilar and their approval process in us market |
| 2 | Yashwanth J | Dr. R. Kamaraj | Marketing registration of tranexamic acid usp 500mg as per regulatory requirements of tanzania and uganda |
| 3 | Tamil selvan R | Dr. R. Kamaraj | Navigating the landscape of post approval changes and their impact in the pharmaceuticals as per usfda |
| 4 | Krishna kumar T | Dr. R. Kamaraj | Project management strategies involved in the development of biosimilar and their approval process in european market |
| 5 | Syed areef H | Dr. R. Kamaraj | Project management strategies for developing and approving a revlimid generic in the eu |
| 6 | Ashokkumar G | Dr. R. Kamaraj | Project management strategies involved in the development of generic drugs and their approval process in us market |
| 7 | Chandru S | Mr. T. Sudheer kumar | A comprehensive analysis of chemistry manufacturing and control of voclosporin 7.9 mg capsules for anda filing in us market |
| 8 | Swapti ranjan | Mr. T. Sudheer kumar | A comprehensive analysis of change control procedures and post approval regulatory requirements as per south africa, zimbabwe and tanzania |
| 9 | Mohammad abid ansari | Dr. R. Kamaraj | Regulatory requirements for drug, device and biologicals of combination products as per usfda guidelines |
| 10 | Rishita ghosh | Mr. T. Sudheer kumar | Navigation of regulatory dossiers in west african countries (nigeria and ghana) |
| 11 | Mohamed hunais t | Dr. R. Kamaraj | Contrast of regulatory requirements for the marketing authorization of generic drugs in kenya and zambia |
| 12 | Sanidhya sohni | Mr. T. Sudheer kumar | A comprehensive analysis of cmc requirements in accordance with malaysia npra actd format |
Menu
